Gyroscope Therapeutics announced today that it received a commitment from Sanofi (NYSE:SNY) to invest up to $60 million. London-based Gyroscope will receive a $40 million investment from Sanofi initially. That $40 million represents a premium to Gyroscope’s previous Series C financing, with the remaining $20 million to be invested contingent on a future qualifying investment […]
Gyroscope Therapeutics
Gyroscope Therapeutics launches IPO roadshow
Gyroscope Therapeutics announced today that it launched the roadshow for its initial public offering of nearly 7 million shares. London-based Gyroscope’s U.S. offering includes up to 6.75 million American Depository Shares (ADSs) representing 6.75 million ordinary shares, according to a news release. Gyroscope expects pricing for the IPO to range between $20 and $22 per […]
Gyroscope Therapeutics raises $148M Series C
Gyroscope Therapeutics announced today that it raised $148 million (£107.8 million) in a Series C financing round. Forbion’s Growth Opportunities Fund led the round, while Sofinnova Investments, funds and accounts advised by T. Rowe Price, Tetragon Financial, Fosun Pharma, Cambridge Innovation Capital and Syncona, along with an undisclosed fund, contributed. In conjunction with the financing, […]
